<?xml version="1.0"?>
<!DOCTYPE TimeML SYSTEM "TimeML.dtd">
<TimeML>
| Topix    
The price of Bristol-Myers Squibb Company shares have declined to $47.74, which is only 3.6% above <TIMEX3 tid="t1" type="DURATION" value="P3Y">the three-year</TIMEX3> low of $46.01. Bristol-Myers Squibb is an American pharmaceutical company that manufactures prescription pharmaceuticals in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease and diabetes. 
 Related Biotechnology, Pharmaceutical and Healthcare News   
Original Article: Stocks Reach Their '-Year Low Prices 
  NEXT ARTICLE  More From BioPortfolio on "Stocks Reach Their '-Year Low Prices"
</TimeML>
